SPONSOR
Region Skane
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 2, Phase 3, Phase 4
Conditions studied: MelanomaMelanoma in SituDysplastic NeviMole (Dermatology)ImageMutationAnorexia NervosaGender Dysphoria, AdultMeniscus RuptureMeniscus Injury
Region Skane is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Melanoma, Melanoma in Situ, Dysplastic Nevi, Mole (Dermatology).
The trial portfolio spans Phase 2, Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Region Skane
How many clinical trials has Region Skane sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Region Skane, of which 10 are actively recruiting participants. These trials cover conditions including Melanoma, Melanoma in Situ, Dysplastic Nevi. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Region Skane research focus on?
Region Skane clinical trials span Melanoma, Melanoma in Situ, Dysplastic Nevi, Mole (Dermatology), Image, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Region Skane clinical trial?
To participate in a Region Skane trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Region Skane trials with current recruitment status updated daily.
Clinical Trials by Region Skane
NCT05446155
Recruiting
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Melanoma
NCT07169747 Phase 2
Recruiting
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
Anorexia Nervosa
NCT07480590
Recruiting
GLOW: Gender-Affirming Care and Mental Health: A Longitudinal Study On Quality of Life, Work Life, and Healthcare Outcomes
Gender Dysphoria, Adult
NCT07079254
Recruiting
Surgical Outcome After Displaced Bucket-handle Meniscal Lesions - Repair Versus Partial Meniscectomy
Meniscus Rupture
NCT06540222
Recruiting
Sustained Cord Circulation at Emergency Cesarean Section
Asphyxia Neonatorum
NCT07184684 Phase 2, Phase 3
Recruiting
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).
Chronic Rhinosinusitis Without Nasal Polyps
NCT06211504 Phase 4
Recruiting
Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity
Acquired Adult Flatfoot Deformity
NCT07564778
Recruiting
Pain After Cardiac Arrest and Resuscitation (PAINCARE)
Pain
NCT07511673
Recruiting
The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the Outcome of Patients Undergoing Surgical Cardiac Valve Replacement or Transcatheter Cardiac Valve Implantation.
Infective Endocarditis (IE)
NCT07389161
Recruiting
Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
Mb Crohn
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology